search
Back to results

Effectiveness and Implementation of the HiBalance Program in Clinical Practice (BETA-PD)

Primary Purpose

Parkinson Disease

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
HiBalance training program
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease focused on measuring Balance, Rehabilitation, Exercise, basal ganglia, Gait, Training, physical activity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed idiopathic Parkinson's Disease
  • Measured balance impairment (according to the mini-BESTest)
  • Hoehn and Yahr stages 2-3
  • Independent ambulator indoors without a walking aid

Exclusion Criteria:

  • Cognitive impairment which hinders participation in group training
  • The presence of comorbidities which hinder safe participation in group training

Sites / Locations

  • Karolinska institutet

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Balance training group

Control group

Arm Description

1 hour group balance training twice weekly for 10 weeks, as well as perform a home exercise program.

Subjects in this group will receive no intervention and will be advised to continue their normal level of exercise throughout the intervention period.

Outcomes

Primary Outcome Measures

Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention.
Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. Maximum points 28. 0-28 points with higher scores indicating better balance control The mini-BESTest is an assessment of balance performance and will be performed by the physiotherapists in the respective clinics.

Secondary Outcome Measures

Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.
The 10-meter walking test assesses gait performance was performed by the physiotherapists in the respective clinics. Gait speed was measured as m/sec during 10 meters
Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair). Timed Up and Go (TUG) test is measured in seconds it takes to perform the task.
Change in EQ-5D Score From Baseline at 1week Post Intervention.
The EQ-5D is a 2-paged form assessing health-related quality of life and will be filled in by participants. European Quality of Life- 5 dimensions (EQ-5D), The visual analogue scale (VAS) indicates the general health status ranging from 0-100 with 100 indicating the best health status
Change in Activities-specific Balance Confidence (ABC) Scale
The ABC scale assesses self-reported balance confidence and will be filled in by study participants. It consists of 16 items that are rated from from 0-100% where 0% indicates no confidence and 100% complete confidence. The overall score is calculated by adding the item scores and dividing the total by 16 (i.e. the number of items). This total score ranges from 0% to 100%.
Change in Physical Activity Level From Baseline 1 Week Post Intervention.
Participants will wear accelerometers for a 7-day period directly before and after the intervention. Physical activity level (steps per day)
Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair).The TUG COG test involves performance of the TUG test while sequentially subtracting the number 3 from a start number. The time difference between the TUG and the TUG COG reflects dual-task interference during functional mobility and is calculated be expressed as a percentage: (TUG COG - TUG)/TUG.

Full Information

First Posted
March 22, 2016
Last Updated
August 11, 2023
Sponsor
Karolinska Institutet
Collaborators
Karolinska University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02727478
Brief Title
Effectiveness and Implementation of the HiBalance Program in Clinical Practice
Acronym
BETA-PD
Official Title
Highly Challenging Balance Training for People With Parkinson's Disease (the BETA-PD Study): Non-randomized Hybrid Effectiveness-implementation Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
March 28, 2016 (Actual)
Primary Completion Date
February 20, 2018 (Actual)
Study Completion Date
September 28, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Karolinska University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This effectiveness-implementation study is a part of the larger study BETA-PD (Balance, Elderly, Training and Activity in Parkinson's Disease), which has the long-term goal to reduce the risk of falling in people with Parkinson's disease (PD) by improving balance, gait and physical activity level. The main hypothesis is that highly challenging balance training will lead to greater gait and balance ability, increased levels of physical activity and an improved health related quality of life. The main aims of the study are to evaluate the effectiveness of the HiBalance program in real-life clinical settings, while exploring facilitators and barriers for program implementation on a wider scale.
Detailed Description
The clinical features of PD include progressive postural instability, hypokinesia, tremor and rigidity. It is therefore common that people with PD experience reduced balance and gait function, symptoms which can have far-reaching negative effects on their health and quality of life. Injurious falls and fear of falling are especially prevalent among those with PD, a factor which may partly explain why this group are less physically active than older people of a similar age without the diagnosis. Balance and gait training, on the other hand, have been shown effective in PD and also appear to have potential neuro-protective properties. Research in the area of balance training in PD disease however is sparse and previous interventions have been criticized for applying training stimuli which lacked intensity and challenge. The HiBalance program is based on scientifically well-established principles of exercise training and postural control as well as current research on training in PD. The program was developed to affect symptom-specific balance impairments in PD by targeting four main subsystems underlying balance control (stability limits, anticipatory postural adjustments, sensory integration and motor agility). The intervention consists of a 10-week progressive balance training program in group format (5-7 participants). Each training session is conducted by a minimum of 2 physiotherapist trainers, during twice weekly 1-hour sessions (20 hours in total). Additionally, a home-exercise program is carried out by the participants once a week during the trial period. The difficulty level of the group-based training is increased in three consecutive blocks. To ensure highly challenging exercises, each task is individually adjusted by altering the area of base of support, increasing movement speed/amplitude and/or restricting vision and varying the grade of multitasking. The program has previously been proven feasible [Conradsson, 2012] and effective [Conradsson, 2015] in improving balance and gait impairments in a randomized controlled hospital setting. In addition, favorable transfer effects were seen in relation to physical activity levels and the performance of activities of everyday life. For research interventions to be adopted in real-life clinical settings however a level of adaptation is required. Best practice then involves evaluating the effectiveness of efficacious programs in clinical settings, in order to verify whether or not the adaptation has attenuated the effective core elements of the program itself. The current study combines a clinical effectiveness trial together with implementation research. Use of a type-1 hybrid design will allow the effects of the HiBalance program in clinical settings to be tested while simultaneously gathering information on barriers and facilitators to the implementation process [Curran, 2012]. Use of the hybrid design also allows for constant monitoring of the process by which the intervention is applied, and therefore allow problems in early application to be identified and quickly altered so as to ensure better outcomes. A participatory approach will be adhered to whereby 'users' of the program (physiotherapist trainers) will be actively involved in all stages of the program adaptation, process and outcome evaluation. This approach is recommended in order to increase the relevance, acceptability and successful implementation of the program. The Consolidated Framework for Implementation Research (CFIR) will be used in the current study to guide the investigation of potential barriers to and facilitators of the implementation process [Damschroder, 2009 ].

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
Balance, Rehabilitation, Exercise, basal ganglia, Gait, Training, physical activity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
117 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Balance training group
Arm Type
Experimental
Arm Description
1 hour group balance training twice weekly for 10 weeks, as well as perform a home exercise program.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Subjects in this group will receive no intervention and will be advised to continue their normal level of exercise throughout the intervention period.
Intervention Type
Other
Intervention Name(s)
HiBalance training program
Intervention Description
The program consists of physiotherapist led highly challenging balance exercises, which are adapted and progressed on both a group and individual basis throughout the training period.
Primary Outcome Measure Information:
Title
Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention.
Description
Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. Maximum points 28. 0-28 points with higher scores indicating better balance control The mini-BESTest is an assessment of balance performance and will be performed by the physiotherapists in the respective clinics.
Time Frame
Change in Mini-BESTest score from baseline at 1 week post intervention.
Secondary Outcome Measure Information:
Title
Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.
Description
The 10-meter walking test assesses gait performance was performed by the physiotherapists in the respective clinics. Gait speed was measured as m/sec during 10 meters
Time Frame
From baseline at 1 week post intervention.
Title
Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
Description
The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair). Timed Up and Go (TUG) test is measured in seconds it takes to perform the task.
Time Frame
From baseline at 1 week post intervention.
Title
Change in EQ-5D Score From Baseline at 1week Post Intervention.
Description
The EQ-5D is a 2-paged form assessing health-related quality of life and will be filled in by participants. European Quality of Life- 5 dimensions (EQ-5D), The visual analogue scale (VAS) indicates the general health status ranging from 0-100 with 100 indicating the best health status
Time Frame
From baseline at 1week post intervention.
Title
Change in Activities-specific Balance Confidence (ABC) Scale
Description
The ABC scale assesses self-reported balance confidence and will be filled in by study participants. It consists of 16 items that are rated from from 0-100% where 0% indicates no confidence and 100% complete confidence. The overall score is calculated by adding the item scores and dividing the total by 16 (i.e. the number of items). This total score ranges from 0% to 100%.
Time Frame
From baseline at 1 week post intervention.
Title
Change in Physical Activity Level From Baseline 1 Week Post Intervention.
Description
Participants will wear accelerometers for a 7-day period directly before and after the intervention. Physical activity level (steps per day)
Time Frame
from baseline to 1 week post intervention
Title
Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
Description
The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair).The TUG COG test involves performance of the TUG test while sequentially subtracting the number 3 from a start number. The time difference between the TUG and the TUG COG reflects dual-task interference during functional mobility and is calculated be expressed as a percentage: (TUG COG - TUG)/TUG.
Time Frame
From baseline at 1 week post intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed idiopathic Parkinson's Disease Measured balance impairment (according to the mini-BESTest) Hoehn and Yahr stages 2-3 Independent ambulator indoors without a walking aid Exclusion Criteria: Cognitive impairment which hinders participation in group training The presence of comorbidities which hinder safe participation in group training
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erika Franzén, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska institutet
City
Stockholm
State/Province
Södermanland
ZIP/Postal Code
14183
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
23017069
Citation
Conradsson D, Lofgren N, Stahle A, Hagstromer M, Franzen E. A novel conceptual framework for balance training in Parkinson's disease-study protocol for a randomised controlled trial. BMC Neurol. 2012 Sep 27;12:111. doi: 10.1186/1471-2377-12-111.
Results Reference
background
PubMed Identifier
25608520
Citation
Conradsson D, Lofgren N, Nero H, Hagstromer M, Stahle A, Lokk J, Franzen E. The Effects of Highly Challenging Balance Training in Elderly With Parkinson's Disease: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2015 Oct;29(9):827-36. doi: 10.1177/1545968314567150. Epub 2015 Jan 21.
Results Reference
background
PubMed Identifier
22310560
Citation
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
Results Reference
background
PubMed Identifier
19664226
Citation
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.
Results Reference
background
PubMed Identifier
31834166
Citation
Leavy B, Joseph C, Lofgren N, Johansson H, Hagstromer M, Franzen E. Outcome Evaluation of Highly Challenging Balance Training for People With Parkinson Disease: A Multicenter Effectiveness-Implementation Study. J Neurol Phys Ther. 2020 Jan;44(1):15-22. doi: 10.1097/NPT.0000000000000298.
Results Reference
result
PubMed Identifier
33526031
Citation
Leavy B, Joseph C, Kwak L, Franzen E. Implementation of highly challenging balance training for Parkinson's disease in clinical practice: a process evaluation. BMC Geriatr. 2021 Feb 1;21(1):96. doi: 10.1186/s12877-021-02031-1.
Results Reference
derived
PubMed Identifier
28173775
Citation
Leavy B, Kwak L, Hagstromer M, Franzen E. Evaluation and implementation of highly challenging balance training in clinical practice for people with Parkinson's disease: protocol for the HiBalance effectiveness-implementation trial. BMC Neurol. 2017 Feb 7;17(1):27. doi: 10.1186/s12883-017-0809-2.
Results Reference
derived

Learn more about this trial

Effectiveness and Implementation of the HiBalance Program in Clinical Practice

We'll reach out to this number within 24 hrs